Analyst Speak:

“The Global Sterile Injectables Market was valued around US$ 385.9 Bn by 2018 and growing at a CAGR of 12.4% over next seven years 2019-2025 due to increasing occurrence of cancer across the globe”.

The global sterile injectables market accounted for US$ 385.9 Bn in 2018 and burgeoning over the forthcoming years. Some of the key factors influencing the market growth include increasing occurrence of cancer across the globe, growing use of biologics in healthcare industry and rising R&D focus on development of biotechnology-engineered anti-cancer drugs, changing lifestyle and rising demand for the better quality of life. However, high expenses associated with inventory management and severe government regulations are the major factors inhibiting the market growth.

Global sterile injectables market segmented on the basis of molecule type, drug type, disease indication, route of administration, distribution channel and region.

Avail Sample Report of the Market @ https://www.precisionbusinessinsights.com/request-sample?product_id=15614

Monoclonal Antibodies dominate the Global Sterile Injectables Market

Based on drug type, global sterile injectables market is monoclonal antibodies, cytokines, insulin, peptide hormones, blood factors, vaccines, immunoglobulins, peptide antibiotics and others. Monoclonal Antibodies held considerable market growth during estimated period. Monoclonal antibodies are identical immunoglobulins, generated from a single B-cell clone. These antibodies recognize unique epitopes, or binding sites, on a single antigen. They identify and bind to antigens in order to distinguish between specific epitopes which offers protection against disease organisms.

They target numerous proteins that impact cell activity such as receptors or other proteins present on the surface of normal and cancer cells. The specificity of monoclonal antibodies permits its binding to cancerous cells by pairing a cytotoxic agent such as a strong radioactive which then seek outs to destroy the cancer cells while not harming the healthy ones.

North America Leads the Global Sterile Injectables market

PBI’s global sterile injectables market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis. North America accounted for larger revenue share in global sterile injectables market with considerable CAGR. The growth in this region can be attributed to increase in spending’s on research and development, expansion of various companies to increase their production capacities and rising acceptance of oncology-related drugs in hospitals. In addition, Asia Pacific held significant market share during estimated period owing to rising awareness about sterile injectable drugs and different types of rules imposed in the region by several government bodies.

 Strategic Acquisitions are the Key Strategies Adopted by Market Players

 Global sterile injectables market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. In 2015 Pfizer Inc. acquired Hospira, Inc., world’s leading provider of injectable and infusion technologies.

Key player’s profiles in the report are AbbVie Inc. (U.S), Amgen Inc. (U.S), AstraZeneca plc (U.K), Baxter International Inc. (U.S), Eli Lilly and Company (U.S), GILEAD SCIENCES, INC. (U.S), GlaxoSmithKline plc. (U.K), Johnson & Johnson Services, Inc. (U.S), Merck & Co., Inc. (U.S), Novo Nordisk A/S (Denmark), Novartis AG (Switzerland), Pfizer Inc. (U.S), F. Hoffmann-La Roche AG (Switzerland) and Sanofi (France).

Precision Business Insights (PBI) in its report titled “Global Sterile Injectables Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Moreover, the report also includes the total revenue and volume for the market.

For More Information @ https://www.precisionbusinessinsights.com/market-reports/global-sterile-injectables-market/

Detailed Segmentation

 By Molecule Type                          

Large Molecules
Small Molecules

By Drug Type                    

Monoclonal Antibodies
Cytokines
Insulin
Peptide Hormones
Blood Factors
Vaccines
Immunoglobulins
Peptide Antibiotics
Others

By Disease Indication                   

Cancer
Diabetes
Cardiovascular Diseases
Musculoskeletal
CNS
Infections
Others

By Route of Administration                      

Intravenous (IV)
Intramuscular (IM)
Subcutaneous (SC)
Others

By Distribution Channel                              

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies                

 By Geography

North America

US
Canada

Europe

Germany
France
UK
Italy
Spain
Russia
Poland
Rest of Europe

Asia-Pacific

Japan
China
India
Australia & New Zealand
ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
South Korea
Rest of Asia-Pacific

Latin America

Brazil
Mexico
Argentina
Rest of Latin America

Middle East and Africa (MEA)

Gulf Cooperation Council (GCC) Countries
Israel
South Africa
Rest of MEA

About Us:
 
Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.
 
Contact Us:
 
Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights